Pharmaceuticals
Company Overview of Ancora Pharmaceuticals, Inc.
Executive Profile
Karl E. WhiteChairman, Ancora Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 2 Board Members in 2 different organizations across 1 different industries. See Board Relationships |
| -- | -- |
Background
Mr. Karl E. White is the Managing Principal of Gracián & Co., LLC. Previously, he was the Chief Investment Officer at Fletcher Asset Management. Mr. White has also worked in the Global Asset Allocation Group at Putnam Investments, where he specialized in tactical asset allocation and currency overlay strategies. He has also held investment management positions at Scudder Kemper and Goldman Sachs Asset Management. Mr. White Chairs the Board of Directors of Ancora Pharmaceuticals, ...
Corporate Headquarters200 Boston AvenueMedford, Massachusetts 02155 United States Phone: 781-395-7700 Fax: 781-395-7900 Board Members MembershipsTrustee Chairman
EducationBS 1988 Florida A & M University MBA 1995 The University of Chicago Booth School of Business
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |

COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Chapel Hill, NC | Cempra PharmaceuticalsPosted: Jun 11
- Connecticut | Boehringer IngelheimPosted: May 27
- Bakersfield, CA | AstraZenecaPosted: Jun 17
- Miami Beach, FL | Pain Fiber Nerve Conduction StudiesPosted: Jun 17
Sponsored Financial Commentaries
Sponsored Links
To contact Ancora Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








